We then assessed the relationships between genomic subtypes and clinical characteristics and found that genomic subtypes were significantly associated with T stage, tumor grade, and EORTC scores, with a gradual escalation observed among the FGFR3/HRAS, FGFR3 & chr9Del, GI, and AA-like subtypes (Figure S14 A). Here, HRAS is linked to neoplasm.